College News

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer.

Second-year University of Oklahoma pediatric resident Dr. Caroline Thompson has a professional and personal connection to cystic fibrosis patient care for children. A childhood friend had the disease and made a lasting impression on Thompson. Now, Thompson has received the Cystic Fibrosis Foundation’s Medical Resident Research Award for a pilot study evaluating pharmacogenomic-directed therapy for pediatric patients at the Oklahoma Cystic Fibrosis Center Tulsa.

Yuri Lansinger, M.D., associate professor with the Department of Orthopedic Surgery at the University of Oklahoma College of Medicine and a board-certified orthopedic surgeon specializing in hand surgery, has received the Fulbright U.S. Scholar award for the 2024-2025 academic year.

A University of Oklahoma study about a “black box warning” for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side effects in children and adolescents.

Like alien invaders in a sci-fi movie, pancreatic cancer cells quickly adapt to the weapons used against them and find ways to survive, even in the harshest of conditions. Understanding why is the aim of cancer scientists everywhere. A University of Oklahoma College of Medicine researcher recently advanced the knowledge of pancreatic cancer with a study about how it acclimates to and even thrives in a highly acidic environment. The research is published in the current issue of the journal Nature Cell Biology.